MultiplexDX

Description

Develops multiplexed, quantitative diagnostic tests for cancer and infectious diseases; provides assays and services such as breast cancer diagnostics, COVID-19 tests, RNA sequencing and bioinformatics.

Related

• Oy Medix Biochemica AbOy Medix Biochemica supplies raw materials and reagents for assays.
• Uniogen OyUniogen develops diagnostic assays, instruments, and contract manufacturing services for earlier, more accurate cancer detection and life…
• Aidian OyAidian develops, makes, and distributes CE-marked in vitro diagnostic tests.
• AltraTechDevelops a multimodal molecular diagnostic platform that simultaneously detects and quantifies DNA, RNA, antibodies, and antigens for…
• TareBioDevelops vaccines intended for cancer and infectious diseases, addressing needs in oncology and infection prevention or treatment for…
• SEQUENTIA BIOTECH SLBuilds bioinformatics software and provides consulting to turn omics data into actionable insights for research institutions, pharma,…
• Ångström AIDevelops diagnostics using amplicon sequencing and machine learning, aiming to broaden access to sequencing-based diagnostic methods for…
• Owlstone MedicalDevelops Breath Biopsy products and services for comprehensive analysis of volatile organic compounds, enabling non-invasive diagnostic…
• EndomagBuilds a surgical guidance platform using magnetic technologies for identifying and removing breast cancer, used by physicians and…
• Atomic AIBuilds RNA foundation models and wet-lab assays to predict RNA structure and function, supporting discovery of RNA-targeted small molecules…
• BioPorto A/SDevelops diagnostic biomarker tests and kits; provides the NGAL test and ELISA kits to clinicians and researchers for early acute kidney…
• THERAPANACEABuilds AI-driven oncology software and platforms for clinical teams and cancer centers to support segmentation, planning, and adaptive…